-
1 Comment
Medikit Co.,Ltd is currently in a long term downtrend where the price is trading 1.5% below its 200 day moving average.
From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Medikit Co.,Ltd's total revenue sank by 4.2% to $5B since the same quarter in the previous year.
Its net income has dropped by 5.4% to $783M since the same quarter in the previous year.
Based on the above factors, Medikit Co.,Ltd gets an overall score of 1/5.
| Exchange | TSE |
|---|---|
| ISIN | JP3921060004 |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Dividend Yield | 3.5% |
|---|---|
| PE Ratio | 11.86 |
| Target Price | None |
| Beta | 0.17 |
| Market Cap | 36B |
Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath and Mongoose. Its products are used in anesthetic departments, operating theaters, ICUs, and dialysis and cardiology units. The company markets its products through distributors in approximately 20 countries and territories in the European Union and on the American continent. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7749.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
